Cargando…

In search of clinically relevant parameters to monitor successful omalizumab therapy in allergic asthma

Background: Omalizumab is approved as add-on therapy for the treatment of severe uncontrolled allergic asthma. Increase in quality of life and decrease of exacerbations and hospital admission, as well as immunmodulatory effects have been described with omalizumab therapy. However, to date there are...

Descripción completa

Detalles Bibliográficos
Autores principales: Probst, M., Gogolka, A., Krüll, M., Noga, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881860/
https://www.ncbi.nlm.nih.gov/pubmed/31826042
http://dx.doi.org/10.5414/ALX01377E